US 10080730
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells
granted A61KA61K31/557A61K31/5585
Quick answer
US patent 10080730 (Treatment of vasculopathy with prostacyclin and mesenchymal stem cells) held by United Therapeutics Corporation expires Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United Therapeutics Corporation
- Grant date
- Tue Sep 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/557, A61K31/5585, A61K35/28, A61P